Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11163 | 937 | 29.0 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
481 | 14973 | ORGAN DONATION//LIVING KIDNEY DONATION//PROGRESS IN TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ONCE DAILY TACROLIMUS | Author keyword | 15 | 88% | 1% | 7 |
2 | TACROLIMUS ONCE DAILY | Author keyword | 6 | 80% | 0% | 4 |
3 | SECT NEPHROL HYPERTENS TRANSPLANTAT MED | Address | 6 | 71% | 1% | 5 |
4 | IMMUNOSUPPRESSANT ADHERENCE | Author keyword | 6 | 100% | 0% | 4 |
5 | ADVAGRAF | Author keyword | 5 | 63% | 1% | 5 |
6 | CRIT CARE CARDIO P | Address | 4 | 67% | 0% | 4 |
7 | PROLONGED RELEASE TACROLIMUS | Author keyword | 4 | 67% | 0% | 4 |
8 | RENAL RECIPIENTS | Author keyword | 4 | 75% | 0% | 3 |
9 | TRANSPLANT REGENERAT MED | Address | 4 | 75% | 0% | 3 |
10 | ACUTE TERTIARY CARE NURSING | Address | 3 | 57% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCE DAILY TACROLIMUS | 15 | 88% | 1% | 7 | Search ONCE+DAILY+TACROLIMUS | Search ONCE+DAILY+TACROLIMUS |
2 | TACROLIMUS ONCE DAILY | 6 | 80% | 0% | 4 | Search TACROLIMUS+ONCE+DAILY | Search TACROLIMUS+ONCE+DAILY |
3 | IMMUNOSUPPRESSANT ADHERENCE | 6 | 100% | 0% | 4 | Search IMMUNOSUPPRESSANT+ADHERENCE | Search IMMUNOSUPPRESSANT+ADHERENCE |
4 | ADVAGRAF | 5 | 63% | 1% | 5 | Search ADVAGRAF | Search ADVAGRAF |
5 | PROLONGED RELEASE TACROLIMUS | 4 | 67% | 0% | 4 | Search PROLONGED+RELEASE+TACROLIMUS | Search PROLONGED+RELEASE+TACROLIMUS |
6 | RENAL RECIPIENTS | 4 | 75% | 0% | 3 | Search RENAL+RECIPIENTS | Search RENAL+RECIPIENTS |
7 | LCP TACRO | 3 | 100% | 0% | 3 | Search LCP+TACRO | Search LCP+TACRO |
8 | PEDIATRIC TRANSPLANT | 3 | 32% | 1% | 8 | Search PEDIATRIC+TRANSPLANT | Search PEDIATRIC+TRANSPLANT |
9 | PEDIATRIC TRANSPLANTATION | 3 | 13% | 2% | 19 | Search PEDIATRIC+TRANSPLANTATION | Search PEDIATRIC+TRANSPLANTATION |
10 | NON ADHERENCE | 2 | 12% | 2% | 17 | Search NON+ADHERENCE | Search NON+ADHERENCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SUBCLINICAL NONCOMPLIANCE | 54 | 73% | 4% | 41 |
2 | ADVAGRAF | 51 | 91% | 2% | 21 |
3 | PROGRAF BASED REGIMEN | 48 | 74% | 4% | 35 |
4 | PROGRAF | 29 | 75% | 2% | 21 |
5 | 2 YEARS POSTCONVERSION | 23 | 86% | 1% | 12 |
6 | TWICE DAILY PROGRAF | 18 | 83% | 1% | 10 |
7 | MODIFIED RELEASE TACROLIMUS | 15 | 68% | 1% | 13 |
8 | DAILY PROGRAF | 15 | 88% | 1% | 7 |
9 | ONCE DAILY TACROLIMUS | 11 | 67% | 1% | 10 |
10 | RELEASE TACROLIMUS | 11 | 100% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review | 2015 | 3 | 25 | 84% |
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review | 2004 | 190 | 44 | 77% |
The Once-Daily Formulation of Tacrolimus: A Step Forward in Kidney Transplantation? | 2012 | 18 | 20 | 90% |
Once- Versus Twice-Daily Tacrolimus Are the Formulations Truly Equivalent? | 2011 | 35 | 47 | 60% |
Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review | 2005 | 117 | 56 | 57% |
Best practices in the pediatric pretransplant psychosocial evaluation | 2014 | 2 | 56 | 61% |
Interventions to improve medication-adherence after transplantation: a systematic review | 2009 | 50 | 27 | 52% |
Update on the clinical utility of once-daily tacrolimus in the management of transplantation | 2014 | 1 | 38 | 87% |
Adherence in Liver Transplant Recipients | 2011 | 23 | 69 | 48% |
Medication noncompliance and its implications in transplant recipients | 2007 | 52 | 53 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT NEPHROL HYPERTENS TRANSPLANTAT MED | 6 | 71% | 0.5% | 5 |
2 | CRIT CARE CARDIO P | 4 | 67% | 0.4% | 4 |
3 | TRANSPLANT REGENERAT MED | 4 | 75% | 0.3% | 3 |
4 | ACUTE TERTIARY CARE NURSING | 3 | 57% | 0.4% | 4 |
5 | PEDIAT LIVER CARE | 3 | 28% | 1.1% | 10 |
6 | WESSEX RENAL UNIT | 3 | 60% | 0.3% | 3 |
7 | PEDIAT TRANSPLANT PROGRAM | 2 | 67% | 0.2% | 2 |
8 | UGA CLIN PHARM PROGRAM | 2 | 40% | 0.4% | 4 |
9 | ORGAN TRANSPLANT UNIT PARIDE STEFANINI | 2 | 33% | 0.5% | 5 |
10 | SICKKIDS TRANSPLANT | 2 | 25% | 0.7% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000224117 | HEPAT BILIARY PANCREAT SURG LIVER TRANSPLANT UN//ALCOHOL RECIDIVISM//COORDINAC SECTORIAL TRASPLANTES |
2 | 0.0000158306 | TRANSITION TO ADULT CARE//HEALTH CARE TRANSITION//TRANSITION READINESS |
3 | 0.0000124110 | RECOMBINANT HUMAN GROWTH HORMONE//CLIN DEV LEARNING//PEDIATRIC NEPHROLOGY |
4 | 0.0000108226 | ACCESS TO TRANSPLANTATION//SOCIAL ADAPTABILITY INDEX//WAITING LIST |
5 | 0.0000090084 | CYP3A5//TACROLIMUS//CYTOCHROME P450 3A5 |
6 | 0.0000083127 | KDQOL SF//KDQOL//RENAL NURSING |
7 | 0.0000074093 | MEDICATION ADHERENCE//PATIENT COMPLIANCE//MORISKY SCALE |
8 | 0.0000073045 | BERLIN HEART//PEDIATRIC HEART FAILURE//PEDIATRIC HEART TRANSPLANTATION |
9 | 0.0000068108 | SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION//DUAL ORGAN TRANSPLANTATION//COMBINED TRANSPLANTATION |
10 | 0.0000064233 | PUERTO RICO TRANSPLANT PROGRAM//DIALYSIS PROGRAM//HUMAN DIABETES METAB |